InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the full record of transactions filed by Hankey Don, Président du Conseil. Officer active across 1 company, notably Bone Biologics Corp. Cumulatively, 2 disclosures have been published. Activity tracked since 15 October 2021. The latest transaction was disclosed on 13 March 2023 (J). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Don Hankey is the Chairman of the Board of Bone Biologics Corp. As the leader of the board, he is responsible for overseeing the company's activities and strategic direction. Hankey brings extensive business and governance experience, helping to guide the vision and objectives of Bone Biologics. His commitment to excellence is essential for the organization's success.